Advertisement
Cerus Corporation

Cerus Corporation (CERS) Stock Overview

Explore Cerus Corporation’s financial performance, market position, analyst ratings, and future outlook.

CERSNASDAQ
HealthcareMedical - Devices
$2.92
$0.06(2.10%)
U.S. Market opens in 54h 46m
Advertisement

Cerus Corporation (CERS)

Meyka AI Score

Z

Key Financials

Market Cap585.1M
P/E Ratio-56.14
EPS (TTM)$-0.05
ROE-0.15%
Fundamental Analysis

AI Price Forecasts

1 Month$2.63
3 Months$3.04
1 Year Target$2.79

CERS Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Cerus Corporation (CERS) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 63.64, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $2.79.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -56.14 and a market capitalization of 585.1M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
2.10%
5-Day Change
9.36%
1-Month Change
6.96%
3-Month Change
59.56%
6-Month Change
43.84%
Year-to-Date (YTD) Change
41.75%
1-Year Change
114.71%
3-Year Change
23.73%
5-Year Change
-49.22%
All-Time (Max) Change
-75.92%

Contact Information

925 288 6000
1220 Concord Avenue, Concord, CA, 94520

Company Facts

6,140 Employees
IPO DateJan 31, 1997
CountryUS
Actively Trading

Frequently Asked Questions